These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22209065)

  • 1. Decreased vascular endothelial growth factor response to acute hypoglycemia in type 2 diabetic patients with hypoglycemic coma.
    Arnalich F; Maldifassi MC; Atienza G; Ciria E; Quesada A; Cedillo JL; Renart J; Codoceo R; Herruzo R; Montiel C
    Cytokine; 2012 Mar; 57(3):372-8. PubMed ID: 22209065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor during hypoglycemia in patients with type 1 diabetes mellitus: relation to cognitive function and renin-angiotensin system activity.
    Kristensen PL; Høi-Hansen T; Boomsma F; Pedersen-Bjergaard U; Thorsteinsson B
    Metabolism; 2009 Oct; 58(10):1430-8. PubMed ID: 19573885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent effects of hyper- and hypoglycemia on circulating vascular endothelial growth factor in humans.
    Oltmanns KM; Melchert UH; Scholand-Engler HG; Schultes B; Schweiger U; Peters A
    Metabolism; 2008 Jan; 57(1):90-4. PubMed ID: 18078864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased epinephrine responses to hypoglycemia during sleep.
    Jones TW; Porter P; Sherwin RS; Davis EA; O'Leary P; Frazer F; Byrne G; Stick S; Tamborlane WV
    N Engl J Med; 1998 Jun; 338(23):1657-62. PubMed ID: 9614256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof].
    Zhu H; Shi CH
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal, subjective, and neurocognitive responses to brief hypoglycemia in postmenopausal women and age-matched men with type 2 diabetes mellitus.
    Bremer JP; Baron M; Peters H; Oltmanns KM; Kern W; Fehm HL; Born J; Schultes B
    Metabolism; 2006 Mar; 55(3):331-8. PubMed ID: 16483876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antecedent hypoglycaemia attenuates vascular endothelial growth factor response to subsequent hypoglycaemia in healthy men.
    Merl V; Peters A; Oltmanns KM; Kern W; Hubold C; Fehm HL; Born J; Schultes B
    Diabet Med; 2005 Sep; 22(9):1278-81. PubMed ID: 16108863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood glucose estimation and symptoms during hyperglycemia and hypoglycemia in patients with insulin-dependent diabetes mellitus.
    Weinger K; Jacobson AM; Draelos MT; Finkelstein DM; Simonson DC
    Am J Med; 1995 Jan; 98(1):22-31. PubMed ID: 7825615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics.
    Boyle PJ; Schwartz NS; Shah SD; Clutter WE; Cryer PE
    N Engl J Med; 1988 Jun; 318(23):1487-92. PubMed ID: 3285214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High plasma VEGF relates to low carbohydrate intake in patients with type 2 diabetes.
    Hubold C; Oltmanns KM; Schultes B; Jelkmann W; Born J; Fehm HL; Schweiger U; Peters A
    Int J Obes (Lond); 2006 Sep; 30(9):1356-61. PubMed ID: 16534523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and mortality of type 2 diabetic patients hospitalized for severe iatrogenic hypoglycemia.
    Fadini GP; Rigato M; Tiengo A; Avogaro A
    Diabetes Res Clin Pract; 2009 Jun; 84(3):267-72. PubMed ID: 19250694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal and metabolic counterregulation during and after high-dose insulin-induced hypoglycemia in diabetes mellitus type 2.
    Bischof MG; Ludwig C; Hofer A; Kletter K; Krebs M; Stingl H; Nowotny P; Waldhäusl W; Roden M
    Horm Metab Res; 2000 Oct; 32(10):417-23. PubMed ID: 11069207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relaxin expression correlates significantly with serum changes in VEGF in response to antidiabetic treatment in male patients with type 2 diabetes mellitus.
    Schöndorf T; Forst T; Hohberg C; Lübben G; Armbruster FP; Roth W; Borchert M; Köder C; Löbig M; Grabellus M; Pfützner A
    Clin Lab; 2007; 53(3-4):193-8. PubMed ID: 17447657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes.
    Blann AD; Belgore FM; McCollum CN; Silverman S; Lip PL; Lip GY
    Clin Sci (Lond); 2002 Feb; 102(2):187-94. PubMed ID: 11834138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe hypoglycemia in type II diabetes at Nakornping General Hospital: a study on clinical risk factors.
    Sanchai T; Patumanond J
    J Med Assoc Thai; 2011 Dec; 94(12):1435-40. PubMed ID: 22295728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
    Lip PL; Chatterjee S; Caine GJ; Hope-Ross M; Gibson J; Blann AD; Lip GY
    Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors associated with symptomatic hypoglycemia in type 2 diabetes mellitus patients.
    Durán-Nah JJ; Rodríguez-Morales A; Smitheram J; Correa-Medina C
    Rev Invest Clin; 2008; 60(6):451-8. PubMed ID: 19378831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin and vascular endothelial growth factor as risk markers for severe hypoglycaemia in type 1 diabetes.
    Kristensen PL; Pedersen-Bjergaard U; Schalkwijk C; Olsen NV; Thorsteinsson B
    Eur J Endocrinol; 2010 Sep; 163(3):391-8. PubMed ID: 20566589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
    Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
    Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal counterregulation during severe hypoglycaemia under everyday conditions in patients with type 1 and insulin-treated type 2 diabetes mellitus.
    Holstein A; Hammer C; Plaschke A; Ptak M; Kuhn J; Diekmann J; Kleesiek K; Egberts EH
    Exp Clin Endocrinol Diabetes; 2004 Sep; 112(8):429-34. PubMed ID: 15372362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.